AVE avecho biotechnology limited

pre announce, page-9

  1. 5,951 Posts.
    lightbulb Created with Sketch. 398
    I think everyone is failing to see the POH strategy. It is about getting the best deal when the product is selling. A higher sales %. Which would be reduced by upfronts. It also makes the marriage more attractive to the partner.
    And it costs POH nothing.

    This company has pretty much stopped R+D expenses it is fully funded for most of the pipeline. Oxy excepted at this stage.

    It is now just the gap to be filled between these deals being signed and revenue coming in upon product launches.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.5¢
Change
0.000(0.00%)
Mkt cap ! $14.28M
Open High Low Value Volume
0.4¢ 0.5¢ 0.4¢ $39.87K 9.011M

Buyers (Bids)

No. Vol. Price($)
26 23116669 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28544159 25
View Market Depth
Last trade - 12.35pm 23/07/2025 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.